Mitochondrial Calcium Signalling
2023 DATA
Persons in charge
Research
|
LocationLaboratory 321. Severo Ochoa Molecular Biology Center Universidad Autónoma de Madrid. C/ Nicolás Cabrera nº 1, Cantoblanco, 28049 Madrid (España). Key wordsCalcium signalling; Mitochondrial pathophysiology; Neuronal metabolism; Hepatic metabolism; Pathologies associated with mitochondrial transporters. |
Gender perspective
Activity summary
The research carried out by our group focuses on mitochondrial pathophysiology in the brain and liver, in relation to the activity of mitochondrial aspartate/glutamate transporters (AGCs). Thus, it has been established that in hepatocytes deficient in slc25a13/Citrin, the hepatic isoform causing citrullinemia type II (CTLN2), the exogenous expression of slc25a12/Aralar, the specific isoform of excitable tissues, is functional and partially reverses its phenotype. This finding opens up new therapeutic avenues for treating liver diseases caused by SLC25A13/Citrin deficiency.
Contributions to society
Citrullinemia type II (CTLN2), and neonatal intrahepatic cholestasis, caused by a deficiency in SLC25A13/Citrin, are rare diseases more frequent in different areas of Asia for which there are no effective treatments, and which require a search for new therapeutic avenues.
Collaborations
National collaborations: J.M. Cuezva (CBMSO, Autonomous University of Madrid); María José Casarejos (Ramón y Cajal Health Research Institute [IRYSCIS]); Gloria González-Aseguinolaza (CIMA; Pamplona); Alberto Paradela (CNB, CSIC); María Luz Martínez-Chantar (CiCBiogune, Bilbao).
International collaborations: E. R. S. Kunji (MRC, University of Cambridge, UK); T. Saheki (Kagoshima University, Japan).
PhD Theses
List of publications ordered by publication date
IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype.
Domínguez-Zorita S, Romero-Carramiñana I, Santacatterina F, Esparza-Moltó PB, Simó C, Del-Arco A, Núñez de Arenas C, Saiz J, Barbas C, Cuezva JM.
Cell Death Dis. 2023 Jul 12.14(7):413.
PMID: 37433784
FI: 9
Regulation of neuronal energy metabolism by calcium: Role of MCU and Aralar/malate-aspartate shuttle.
Del Arco A, González-Moreno L, Pérez-Liébana I, Juaristi I, González-Sánchez P, Contreras L, Pardo B, Satrústegui J.
Biochim Biophys Acta Mol Cell Res. 2023 Jun.1870(5):119468.
PMID: 36997074
FI: 5,1
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver.
González-Moreno L, Santamaría-Cano A, Paradela A, Martínez-Chantar ML, Martín MÁ, Pérez-Carreras M, García-Picazo A, Vázquez J, Calvo E, González-Aseguinolaza G, Saheki T, Del Arco A, Satrústegui J, Contreras L.
Mol Genet Metab Rep. 2023 Jun.35:100967.
PMID: 36967723
FI: 1,9
A tribute to Sebastián Cerdán and his key contributions to brain metabolism.
Satrustegui J, Larrubia PL, Rodrigues TB, Choi IY, McKenna MC.
J Neurochem. 2023 May 11.
PMID: 37169729
FI: 4,7
Projects, contracts and observational studies
PUBLIC
Sources of public funding for projects being developed at the IIS-FJD:
NA
PRIVATE
NA
Clinical trials
NA